Literature DB >> 21537457

New insights in diabetic foot infection.

Jean-Louis Richard1, Albert Sotto, Jean-Philippe Lavigne.   

Abstract

Foot ulcers are common in diabetic patients, have a cumulative lifetime incidence rate as high as 25% and frequently become infected. The spread of infection to soft tissue and bone is a major causal factor for lower-limb amputation. For this reason, early diagnosis and appropriate treatment are essential, including treatment which is both local (of the foot) and systemic (metabolic), and this requires coordination by a multidisciplinary team. Optimal treatment also often involves extensive surgical debridement and management of the wound base, effective antibiotic therapy, consideration for revascularization and correction of metabolic abnormalities such as hyperglycemia. This article focuses on diagnosis and management of diabetic foot infections in the light of recently published data in order to help clinicians in identification, assessment and antibiotic therapy of diabetic foot infections.

Entities:  

Keywords:  Diabetic foot ulcer; Infection; Management

Year:  2011        PMID: 21537457      PMCID: PMC3083903          DOI: 10.4239/wjd.v2.i2.24

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  71 in total

Review 1.  Topical silver for treating infected wounds.

Authors:  H Vermeulen; J M van Hattem; M N Storm-Versloot; D T Ubbink
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Topical antimicrobial therapy for treating chronic wounds.

Authors:  Benjamin A Lipsky; Christopher Hoey
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

3.  Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A meta-analysis.

Authors:  Mario Cruciani; Benjamin A Lipsky; Carlo Mengoli; Fausto de Lalla
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

4.  Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.

Authors:  N Tentolouris; E B Jude; I Smirnof; E A Knowles; A J Boulton
Journal:  Diabet Med       Date:  1999-09       Impact factor: 4.359

Review 5.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  P Kranke; M Bennett; I Roeckl-Wiedmann; S Debus
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 6.  Unresolved issues in the management of ulcers of the foot in diabetes.

Authors:  W J Jeffcoate; B A Lipsky; A R Berendt; P R Cavanagh; S A Bus; E J G Peters; W H van Houtum; G D Valk; K Bakker
Journal:  Diabet Med       Date:  2008-12       Impact factor: 4.359

7.  Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.

Authors:  A Hartemann-Heurtier; J Robert; S Jacqueminet; G Ha Van; J L Golmard; V Jarlier; A Grimaldi
Journal:  Diabet Med       Date:  2004-07       Impact factor: 4.359

8.  [Methicilline-sensitive and methicilline-resistant Staphylococcus aureus related morbidity in chronic wounds: a prospective study].

Authors:  M Trividic-Rumeau; M-L Bouyssou-Gauthier; M Mounier; A Sparsa; S Blaise; C Bédane; J-M Bonnetblanc
Journal:  Ann Dermatol Venereol       Date:  2003 Jun-Jul       Impact factor: 0.777

9.  Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.

Authors:  T Kästenbauer; B Hörnlein; G Sokol; K Irsigler
Journal:  Diabetologia       Date:  2002-12-06       Impact factor: 10.122

10.  Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.

Authors:  A Jeandrot; J-L Richard; C Combescure; N Jourdan; S Finge; M Rodier; P Corbeau; A Sotto; J-P Lavigne
Journal:  Diabetologia       Date:  2007-10-13       Impact factor: 10.122

View more
  29 in total

1.  In Vitro and In Vivo Antibiotic Capacity of Two Host Defense Peptides.

Authors:  Iván Arenas; Marco Antonio Ibarra; Felix L Santana; Elba Villegas; Robert E W Hancock; Gerardo Corzo
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 2.  Choice of wound care in diabetic foot ulcer: A practical approach.

Authors:  Karakkattu Vijayan Kavitha; Shalbha Tiwari; Vedavati Bharat Purandare; Sudam Khedkar; Shilpa Sameer Bhosale; Ambika Gopalakrishnan Unnikrishnan
Journal:  World J Diabetes       Date:  2014-08-15

3.  Akt/hypoxia-inducible factor-1α signaling deficiency compromises skin wound healing in a type 1 diabetes mouse model.

Authors:  Lifeng Jing; Shuang Li; Qin Li
Journal:  Exp Ther Med       Date:  2015-03-30       Impact factor: 2.447

4.  Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Brian J Werth; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

5.  Severity of diabetic foot infection and rate of limb salvage.

Authors:  Dane K Wukich; Kimberlee B Hobizal; Maria Mori Brooks
Journal:  Foot Ankle Int       Date:  2013-01-14       Impact factor: 2.827

6.  Topical Phenytoin Application in Grade I and II Diabetic Foot Ulcers: A Prospective Study.

Authors:  Vijaya Patil; Rashmi Patil; P L Kariholu; L S Patil; Praveeen Shahapur
Journal:  J Clin Diagn Res       Date:  2013-10-05

7.  Clinico-microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections.

Authors:  Waqas Nasir Chaudhry; Rabia Badar; Muhsin Jamal; Jason Jeong; Jamal Zafar; Saadia Andleeb
Journal:  Exp Ther Med       Date:  2016-01-14       Impact factor: 2.447

8.  Microbial spectrum, antibiotic susceptibility profile, and biofilm formation of diabetic foot infections (2014-18): a retrospective multicenter analysis.

Authors:  Fakhria A Al-Joufi; Khalid M Aljarallah; Soheir A Hagras; Ibrahim M Al Hosiny; Mounir M Salem-Bekhit; Abdullah M E Youssof; Faiyaz Shakeel
Journal:  3 Biotech       Date:  2020-06-30       Impact factor: 2.406

9.  Diabetic foot infection and osteomyelitis. Are deep-tissue cultures necessary?

Authors:  Angeliki M Andrianaki; Christos Koutserimpas; Alexandros Kafetzakis; Emmanouil Tavlas; Sofia Maraki; John A Papadakis; Petros Ioannou; George Samonis; Diamantis P Kofteridis
Journal:  Germs       Date:  2020-12-28

10.  Pathobiochemical changes in diabetic skeletal muscle as revealed by mass-spectrometry-based proteomics.

Authors:  Kay Ohlendieck
Journal:  J Nutr Metab       Date:  2012-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.